ZhengZhou (HQ), Shenzhen (R&D Center), Suzhou (R&D Center), China
MAF/IGH Gene Fusion Detection Kit
Clinic Signification:
1.T (14;16) (Q32;Q22) occurs in 2-6% primary MM, mostly in non-hyperdiploid tumors (NHRD) in MGUS, and is related to the early occurrence of tumors.